Policy Notices

• Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2023 Councils
  (NOT-OD-23-066)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  National Institute for Occupational Safety and Health
  

• Reminder: NIH Natural Disaster Policy California Flooding, Landslides, and Mudslides and Alabama Storms, Straight-line Winds, and Tornadoes
  (NOT-OD-23-069)
  National Institutes of Health
  

General Notices

• Notice of content visibility for tables located in Part 2. Full Text of Announcement in RFA-FD-23-027 "Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed"
  (NOT-FD-23-006)
  Food and Drug Administration
  

• Notice of NHGRI Participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
  (NOT-HG-23-019)
  National Human Genome Research Institute
  

• Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity, Equity, Inclusion, and Accessibility Across NIAID Extramural Activities
  (NOT-AI-23-017)
  National Institute of Allergy and Infectious Diseases
  

• Request for Information on Existing Data Sharing Processes for NIH-Funded Research
  (NOT-CA-23-023)
  National Cancer Institute
  

• Request for Information (RFI): Input for developing the 2024-2028 National Institute of Environmental Health Sciences Strategic Plan
  (NOT-ES-23-005)
  National Institute of Environmental Health Sciences
  

• Request for Information (RFI): Gaps and Opportunities in Global Mental Health Research
  (NOT-MH-23-175)
  National Institute of Mental Health
  

Notice of Changes to Funding Opportunities

• Notice of NIAAA's participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact"
  (NOT-AA-23-007)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of the National Eye Institute participation in NOT-OD-23-044, "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
  (NOT-EY-23-004)
  National Eye Institute
  

• Notice of Clarification for the Research Scope in RFA-HD-24-002 "Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)"
  (NOT-HD-23-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Early Expiration of NOT-HL-21-017, "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)"
  (NOT-HL-23-074)
  National Heart, Lung, and Blood Institute
  

• Notice to expire NIHs Continuity Supplements (NOT-OD-20-054 and NOT-OD-20-055)
  (NOT-OD-23-074)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44)
  (NOT-HL-23-066)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI) for Administrative Supplements: Harmonization and Joint Analysis of Human Brain Single-Cell Datasets
  (NOT-NS-23-042)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Special Interest (NOSI): Revision Applications to add a Curation and Informatics Component to existing Animal and Biological Material Resource Centers (P40) (Clinical Trials Not Allowed)
  (NOT-OD-23-068)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Funding Opportunities

• Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
  (PAR-22-262)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): January 07, 2024
  
  

• Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
  (PAR-23-089)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): March 14, 2024
  
  

• Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required)
  (PAR-23-107)
  Office of Behavioral and Social Sciences Research
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): March 17, 2023
  
  

• Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed)
  (PAR-23-108)
  Office of Behavioral and Social Sciences Research
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): March 17, 2023
  
  

• NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
  (PAR-23-111)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 07, 2026
  
  

• Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
  (PAR-23-112)
  National Institute on Minority Health and Health Disparities
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): January 07, 2026
  
  

• Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)
  (RFA-AG-24-018)
  National Institute on Aging
  Application Receipt Date(s): September 22, 2023
  
  

• Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
  (RFA-EB-23-001)
  National Institute of Biomedical Imaging and Bioengineering
  Office of the Director, NIH
  Application Receipt Date(s): October 02, 2023
  
  

• FDA OMHHE Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH) (U01) Clinical Trials Optional
  (RFA-FD-23-010)
  Food and Drug Administration
  Application Receipt Date(s): April 06, 2023
  
  

• Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
  (RFA-MD-23-002)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 06, 2023
  
  

• Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
  (RFA-MD-23-003)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 06, 2023